Download PDF
CC BY-NC-ND 4.0 · Revista Urología Colombiana / Colombian Urology Journal 2020; 29(03): 113-114
DOI: 10.1055/s-0040-1716515
Editorial

Announcement of the Launch of the Global Society of Rare Genitourinary Tumors (GSRGT)

Lanzamiento de la sociedad global de los tumores genitourinarios raros
Philippe E. Spiess 
1   Department of GU Oncology and Tumor Biology, Moffitt Cancer Center, Tampa, Flórida, EUA
2   Global Society of Rare GU Tumors
,
Andrea Necchi
2   Global Society of Rare GU Tumors
3   Department of Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano, Italy
› Author Affiliations
› Further Information
Also available at
 
 PDF Download Permissions and Reprints

    The care of patients diagnosed with rare genitourinary tumors have often been compromised by the lack of standardization in the diagnostic evaluation and therapeutic management in significant part due to the lack of regional or national expertise in the management of such malignancies and/or the paucity of information supporting an evidence based approach to these conditions. The GSRGT embraces the involvement of all international countries and colleagues in this effort and in fact we would like to insure under-represented parts of the world have a significant representation and voice within the society. In this regard, we are very pleased to announce the formal establishment and launch of the Global Society of Rare GU Tumors which is solely dedicated to advancing the care for these rare genitourinary tumors through promoting optimal treatment strategies, innovative research, and a comprehensive education platform for patients, families, and the entire healthcare team along with a commitment to patient advocacy. The GSRGT will gather international thought leaders with expertise on the subject matter and we are honored to share the schema of our leadership team and governing council (please see attached). This society was created as an impetus that these rare tumors are poorly studied and constitute a diagnostic and treatment conundrum and that a dedicated commitment to their care and study would be quite impactful in improving patient outcomes and quality of life in addition to fostering opportunities for research collaborations.

    We welcome all interested colleagues and friends to join our society using its newly developed webpage https://www.gsrgt.com (and accessing the membership icon to join as new members). The Web site will be continually updated to provide you with the most up-to-date information on our exciting initiatives through our many working groups and subcommittees. In addition, new members of our society (will have at no ensuing charges) be able to attend our planned 1st Global Summit which will be held virtually on Friday December 4th and Saturday December 5th, 2020. Feel free to visit and/or follow the Twitter page for the Global Society of Rare GU Tumors (@GTumors) as well.

    Warm regards and looking forward to hearing from you all.

    Zoom Image

    #

    No conflict of interest has been declared by the author(s).

    Address for correspondence

    Philippe Spiess, MD, MS, FACS
    Department of GU Oncology and Tumor Biology, Moffitt Cancer Center
    Tampa, Flórida
    EUA   

    Publication History

    Article published online:
    22 September 2020

    © 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

    Sociedad Colombiana de Urología. Publicado por Thieme Revinter Publicações Ltda
    Rio de Janeiro, Brazil

       Permissions and Reprints
    Zoom Image